drugset / Trial / NCT01260753
Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to explore the activity of UR-63325 in a model of allergic rhinitis induced by nasal allergen challenge to known allergic rhinitis patients otherwise healthy.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | — | Intranasal |
| Subject | UR-63325 | Small molecule | — | — |